HIMSS 2023, Chicago, USA
Patients can now be monitored continuously and extensively at home, reducing hospitalization and saving healthcare expenditure…
Eldad Shemesh, CardiacSense Funder & CEO on Keeping Time to Market during COVID
In a time of social distancing and isolation, technology is enabling patients, caregivers, and clinicians to communicate and monitor health remotely.
CardiacSense has developed a wearable for continuously monitoring vital signs of either inpatients or outpatients.
January 6, 2023
CardiacSense was granted FDA clearance for ECG, Beat-by-Beat Heart Rate, and Oxygen Saturation (SpO2)
The watch will begin shipping in EU as a medical device for continuous…
This is the first medical wristwatch to receive medical regulatory approval for beat by beat heart rate monitoring and A-Fib detection with ECG accuracy
The agreement was signed with a distributor for the company’s product, which monitors detects fever, respiratory and chronic diseases as well as heart arrhythmias at a uniquely precise level of an ECG device
The Company will enable patients to benefit from Cloud-based medical monitoring, on a monthly fee
CardiacSense is a leading manufacturer of a range of wearable devices for the continuous monitoring of heart arrhythmias and blood pressure